Private Advisor Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Private Advisor Group’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-50	Closed	–	–	3955
2020 Q2	$0	Buy	+50	New	+$475	﹤0.01%	4000

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Private Advisor Group's CEMI Position: Q3 2020 in Review

Private Advisor Group sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2020, closing a stake of 50 shares.

Private Advisor Group first reported a position in CEMI in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 59 funds tracked by Wall St. Rank hold CEMI as of Q3 2020.

Private Advisor Group reported no remaining Chembio diagnostics, Inc. position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 50 Chembio diagnostics, Inc. shares in Q3 2020.
Private Advisor Group first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Chembio diagnostics, Inc. position peaked at $0 in Q2 2020.
59 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.